AstraZeneca's COVID-19 Vaccine Candidate Begins Late-stage U.S. Study

AstraZeneca Plc said on Monday it has begun enrolling adults for a U.S.funded, 30,000subject latestage study of its high profile COVID19 vaccine candidate.

from Top Business News- News18.com
via IFTTT